SIMILAR PATTERNS OF AMINO ACIDS FOR 6B94_A_W9TA201
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1c1f | PROTEIN (CONGERIN I) (Congermyriaster) |
PF00337(Gal-bind_lectin) | 6 | HIS A 44ARG A 48ASN A 61TRP A 70GLU A 73ARG A 75 | None | 0.46A | 6b94A-1c1fA:21.6 | 6b94A-1c1fA:26.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1efy | POLY (ADP-RIBOSE)POLYMERASE (Gallus gallus) |
PF00644(PARP)PF02877(PARP_reg) | 4 | ASN A 767ARG A 865HIS A 909GLU A 688 | None | 0.96A | 6b94A-1efyA:undetectable | 6b94A-1efyA:9.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1f4h | BETA-GALACTOSIDASE (Escherichiacoli) |
PF00703(Glyco_hydro_2)PF02836(Glyco_hydro_2_C)PF02837(Glyco_hydro_2_N)PF02929(Bgal_small_N)PF16353(DUF4981) | 4 | HIS A 391HIS A 418TRP A 568ARG A 204 | None MG A3001 (-3.6A)NoneNone | 1.15A | 6b94A-1f4hA:undetectable | 6b94A-1f4hA:5.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1gan | GALECTIN-1 (Rhinellaarenarum) |
PF00337(Gal-bind_lectin) | 7 | HIS A 45ASN A 47ARG A 49HIS A 53ASN A 62TRP A 69GLU A 72 | GAL A 136 (-4.0A)GAL A 136 (-3.8A)NDG A 135 ( 2.8A)GAL A 136 (-3.7A)GAL A 136 (-3.7A)GAL A 136 (-3.7A)NDG A 135 ( 2.6A) | 0.40A | 6b94A-1ganA:24.6 | 6b94A-1ganA:60.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1gan | GALECTIN-1 (Rhinellaarenarum) |
PF00337(Gal-bind_lectin) | 7 | HIS A 45ASN A 47ARG A 49HIS A 53TRP A 69GLU A 72ARG A 74 | GAL A 136 (-4.0A)GAL A 136 (-3.8A)NDG A 135 ( 2.8A)GAL A 136 (-3.7A)GAL A 136 (-3.7A)NDG A 135 ( 2.6A)NDG A 135 (-3.4A) | 0.66A | 6b94A-1ganA:24.6 | 6b94A-1ganA:60.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hlc | HUMAN LECTIN (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 45ASN A 47ARG A 49ASN A 58TRP A 65GLU A 68ARG A 70 | GAL A 998 (-3.8A)GAL A 998 (-4.1A)BGC A 999 ( 2.7A)GAL A 998 (-3.6A)GAL A 998 (-3.7A)BGC A 999 ( 2.8A)BGC A 999 (-4.3A) | 0.55A | 6b94A-1hlcA:23.4 | 6b94A-1hlcA:30.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1hle | HORSE LEUKOCYTEELASTASE INHIBITORHORSE LEUKOCYTEELASTASE INHIBITOR (Equus caballus;Equus caballus) |
PF00079(Serpin)PF00079(Serpin) | 4 | HIS A 287ASN B 365ASN A 285ARG A 238 | None | 1.16A | 6b94A-1hleA:undetectable | 6b94A-1hleA:13.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1lpb | LIPASE (Homo sapiens) |
PF00151(Lipase)PF01477(PLAT) | 4 | ASN B 100ARG B 68ASN B 63GLU B 44 | None | 1.10A | 6b94A-1lpbB:undetectable | 6b94A-1lpbB:12.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q5a | EP-CADHERIN (Mus musculus) |
PF00028(Cadherin) | 4 | ASN A 143ASN A 104GLU A 69ARG A 68 | NoneNone CA A 906 ( 2.4A)None | 0.00A | 6b94A-1q5aA:undetectable | 6b94A-1q5aA:7.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1qmj | BETA-GALACTOSIDE-BINDING LECTIN (Gallus gallus) |
PF00337(Gal-bind_lectin) | 8 | HIS A 44ASN A 46ARG A 48HIS A 52ASN A 61TRP A 68GLU A 71ARG A 73 | None | 0.50A | 6b94A-1qmjA:25.6 | 6b94A-1qmjA:58.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1slc | BOVINE GALECTIN-1 (Bos taurus) |
PF00337(Gal-bind_lectin) | 8 | HIS A 44ASN A 46ARG A 48HIS A 52ASN A 61TRP A 68GLU A 71ARG A 73 | GAL A 352 ( 3.8A)GAL A 352 ( 4.2A)NAG A 351 ( 3.1A)GAL A 352 (-3.5A)GAL A 352 ( 3.8A)GAL A 352 (-4.3A)NAG A 351 ( 2.8A)NAG A 351 ( 3.0A) | 0.70A | 6b94A-1slcA:27.4 | 6b94A-1slcA:90.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tmo | TRIMETHYLAMINEN-OXIDE REDUCTASE (Shewanellamassilia) |
PF00384(Molybdopterin)PF01568(Molydop_binding) | 4 | HIS A 643ASN A 700ARG A 702GLU A 632 | None | 1.01A | 6b94A-1tmoA:undetectable | 6b94A-1tmoA:7.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tuh | HYPOTHETICAL PROTEINEGC068 (unculturedbacterium) |
PF12680(SnoaL_2) | 4 | ARG A 130ASN A 50GLU A 49ARG A 68 | None | 1.07A | 6b94A-1tuhA:undetectable | 6b94A-1tuhA:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ule | GALECTIN-2 (Coprinopsiscinerea) |
PF00337(Gal-bind_lectin) | 6 | HIS A 51ARG A 55ASN A 64TRP A 72GLU A 75ARG A 77 | GAL A 152 (-3.8A)NAG A 153 ( 2.8A)GAL A 152 (-3.9A)GAL A 152 (-3.8A)NAG A 153 ( 2.8A)NAG A 153 (-3.5A) | 0.48A | 6b94A-1uleA:16.1 | 6b94A-1uleA:27.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1v29 | NITRILE HYDRATASE ACHAINNITRILE HYDRATASE BCHAIN (Bacillussmithii;Bacillussmithii) |
PF02979(NHase_alpha)PF02211(NHase_beta) | 4 | ARG B 200ASN B 212GLU A 167ARG A 169 | None | 1.18A | 6b94A-1v29B:undetectable | 6b94A-1v29B:14.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wlc | CONGERIN II (Congermyriaster) |
PF00337(Gal-bind_lectin) | 6 | HIS A 44ARG A 48ASN A 61TRP A 69GLU A 72ARG A 74 | MES A 777 ( 4.6A)NoneNoneNoneNoneNone | 0.51A | 6b94A-1wlcA:24.0 | 6b94A-1wlcA:29.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ww6 | GALECTIN (Agrocybecylindracea) |
PF00337(Gal-bind_lectin) | 5 | HIS A 62ARG A 66ASN A 75TRP A 83ARG A 88 | GAL A 200 (-4.1A)BGC A 201 ( 3.0A)GAL A 200 (-3.7A)GAL A 200 (-3.6A)BGC A 201 ( 4.3A) | 0.84A | 6b94A-1ww6A:14.6 | 6b94A-1ww6A:20.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ww6 | GALECTIN (Agrocybecylindracea) |
PF00337(Gal-bind_lectin) | 5 | HIS A 62ARG A 66ASN A 75TRP A 83GLU A 86 | GAL A 200 (-4.1A)BGC A 201 ( 3.0A)GAL A 200 (-3.7A)GAL A 200 (-3.6A)BGC A 201 ( 3.1A) | 0.73A | 6b94A-1ww6A:14.6 | 6b94A-1ww6A:20.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2d6l | LECTIN, GALACTOSEBINDING, SOLUBLE 9 (Mus musculus) |
PF00337(Gal-bind_lectin) | 4 | HIS X 60ASN X 62ARG X 43TRP X 81 | None | 1.00A | 6b94A-2d6lX:19.2 | 6b94A-2d6lX:33.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2d6l | LECTIN, GALACTOSEBINDING, SOLUBLE 9 (Mus musculus) |
PF00337(Gal-bind_lectin) | 7 | HIS X 60ASN X 62ARG X 64ASN X 74TRP X 81GLU X 84ARG X 86 | None | 0.52A | 6b94A-2d6lX:19.2 | 6b94A-2d6lX:33.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dyc | GALECTIN-4 (Mus musculus) |
PF00337(Gal-bind_lectin) | 6 | HIS A 63ASN A 65ARG A 67ASN A 77TRP A 84GLU A 87 | None | 0.61A | 6b94A-2dycA:18.9 | 6b94A-2dycA:26.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2kuc | PUTATIVEDISULPHIDE-ISOMERASE (Bacteroidesthetaiotaomicron) |
PF00085(Thioredoxin) | 4 | ASN A 62ARG A 9GLU A 23ARG A 19 | None | 1.09A | 6b94A-2kucA:undetectable | 6b94A-2kucA:19.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2nsm | CARBOXYPEPTIDASE NCATALYTIC CHAIN (Homo sapiens) |
PF00246(Peptidase_M14)PF13620(CarboxypepD_reg) | 4 | ASN A 194HIS A 66ASN A 203GLU A 288 | NoneSO4 A1776 (-4.2A)NoneSO4 A1776 ( 4.7A) | 1.04A | 6b94A-2nsmA:undetectable | 6b94A-2nsmA:12.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r0h | CGL3 LECTIN (Coprinopsiscinerea) |
PF00337(Gal-bind_lectin) | 5 | HIS A 60ARG A 64ASN A 73GLU A 84ARG A 86 | CTO A 165 (-3.6A)CTO A 165 (-2.6A)CTO A 165 (-4.1A)CTO A 165 (-2.7A)CTO A 165 ( 4.0A) | 0.55A | 6b94A-2r0hA:14.4 | 6b94A-2r0hA:18.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wsu | PUTATIVE FIBERPROTEIN (PorcinemastadenovirusB) |
PF00337(Gal-bind_lectin) | 7 | HIS A 435ASN A 437ARG A 439ASN A 451TRP A 459GLU A 462ARG A 464 | None | 0.68A | 6b94A-2wsuA:18.5 | 6b94A-2wsuA:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wsu | PUTATIVE FIBERPROTEIN (PorcinemastadenovirusB) |
PF00337(Gal-bind_lectin) | 5 | HIS A 593ASN A 595ASN A 609TRP A 616GLU A 619 | GOL A1686 (-4.0A)NoneGOL A1686 (-3.7A)GOL A1686 (-3.7A)GOL A1686 (-4.2A) | 0.79A | 6b94A-2wsuA:18.5 | 6b94A-2wsuA:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wyh | ALPHA-MANNOSIDASE (Streptococcuspyogenes) |
PF01074(Glyco_hydro_38)PF07748(Glyco_hydro_38C)PF09261(Alpha-mann_mid) | 4 | ASN A 348ARG A 369GLU A 17ARG A 16 | None | 0.76A | 6b94A-2wyhA:undetectable | 6b94A-2wyhA:6.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ymz | GALECTIN 2 (Gallus gallus) |
PF00337(Gal-bind_lectin) | 5 | HIS A 45ASN A 47ASN A 58TRP A 65ARG A 70 | None | 0.46A | 6b94A-2ymzA:24.1 | 6b94A-2ymzA:28.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2yro | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 4 | ASN A 63ASN A 74TRP A 81GLU A 84 | None | 0.84A | 6b94A-2yroA:16.8 | 6b94A-2yroA:35.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2yro | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 5 | HIS A 61ASN A 63ASN A 74TRP A 81ARG A 86 | None | 0.76A | 6b94A-2yroA:16.8 | 6b94A-2yroA:35.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zgk | ANTI-TUMOR LECTIN (Agrocybeaegerita) |
PF00337(Gal-bind_lectin) | 6 | HIS A 59ARG A 63ASN A 72TRP A 80GLU A 83ARG A 85 | None | 0.74A | 6b94A-2zgkA:15.0 | 6b94A-2zgkA:19.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2zhl | GALECTIN-9 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 4 | HIS A 61ASN A 63ARG A 44TRP A 82 | GAL A1493 ( 3.9A)GAL A1493 (-3.6A)NAG A1491 (-4.6A)GAL A1493 (-3.7A) | 1.07A | 6b94A-2zhlA:19.9 | 6b94A-2zhlA:32.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2zhl | GALECTIN-9 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 61ASN A 63ARG A 65ASN A 75TRP A 82GLU A 85ARG A 87 | GAL A1493 ( 3.9A)GAL A1493 (-3.6A)NAG A1494 ( 2.8A)GAL A1493 (-3.9A)GAL A1493 (-3.7A)NAG A1494 ( 2.7A)NAG A1494 (-4.0A) | 0.41A | 6b94A-2zhlA:19.9 | 6b94A-2zhlA:32.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ajy | ANCESTRAL CONGERINCON-ANC (-) |
PF00337(Gal-bind_lectin) | 5 | HIS A 44ARG A 48ASN A 61TRP A 68GLU A 71 | GAL A 136 (-3.9A)BGC A 135 ( 2.9A)GAL A 136 (-3.7A)GAL A 136 (-3.5A)BGC A 135 ( 2.6A) | 0.48A | 6b94A-3ajyA:22.0 | 6b94A-3ajyA:43.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ajy | ANCESTRAL CONGERINCON-ANC (-) |
PF00337(Gal-bind_lectin) | 5 | HIS A 44ARG A 48TRP A 68GLU A 71ARG A 73 | GAL A 136 (-3.9A)BGC A 135 ( 2.9A)GAL A 136 (-3.5A)BGC A 135 ( 2.6A)BGC A 135 (-4.1A) | 0.84A | 6b94A-3ajyA:22.0 | 6b94A-3ajyA:43.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ajz | ANCESTRAL CONGERINCON-ANC (-) |
PF00337(Gal-bind_lectin) | 5 | HIS A 42ARG A 46ASN A 59TRP A 66GLU A 69 | GAL A 133 (-4.0A)BGC A 134 ( 2.8A)GAL A 133 (-3.8A)GAL A 133 (-3.7A)BGC A 134 ( 2.8A) | 0.39A | 6b94A-3ajzA:24.5 | 6b94A-3ajzA:35.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ajz | ANCESTRAL CONGERINCON-ANC (-) |
PF00337(Gal-bind_lectin) | 5 | HIS A 42ARG A 46TRP A 66GLU A 69ARG A 71 | GAL A 133 (-4.0A)BGC A 134 ( 2.8A)GAL A 133 (-3.7A)BGC A 134 ( 2.8A)BGC A 134 ( 4.4A) | 0.75A | 6b94A-3ajzA:24.5 | 6b94A-3ajzA:35.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ayd | GALECTIN-3 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 158ASN A 160ARG A 162ASN A 174TRP A 181GLU A 184ARG A 186 | GAL A 253 (-3.7A)GAL A 253 (-4.1A)A2G A 252 ( 3.1A)GAL A 253 (-3.9A)GAL A 253 (-3.5A)A2G A 252 (-3.0A)GAL A 256 ( 3.8A) | 0.43A | 6b94A-3aydA:19.4 | 6b94A-3aydA:34.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bga | BETA-GALACTOSIDASE (Bacteroidesthetaiotaomicron) |
PF00703(Glyco_hydro_2)PF02836(Glyco_hydro_2_C)PF02837(Glyco_hydro_2_N)PF02929(Bgal_small_N)PF16353(DUF4981) | 4 | HIS A 413HIS A 440TRP A 579ARG A 230 | None MG A 1 (-3.3A)NoneNone | 1.10A | 6b94A-3bgaA:undetectable | 6b94A-3bgaA:6.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3d36 | SPORULATION KINASE B (Geobacillusstearothermophilus) |
PF00512(HisKA)PF02518(HATPase_c) | 4 | HIS A 213ASN A 217GLU A 214ARG A 252 | None | 1.17A | 6b94A-3d36A:undetectable | 6b94A-3d36A:14.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dec | BETA-GALACTOSIDASE (Bacteroidesthetaiotaomicron) |
PF00703(Glyco_hydro_2)PF02836(Glyco_hydro_2_C)PF02837(Glyco_hydro_2_N)PF02929(Bgal_small_N)PF16353(DUF4981) | 4 | HIS A 389HIS A 416TRP A 555ARG A 206 | None | 1.10A | 6b94A-3decA:undetectable | 6b94A-3decA:6.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3dui | BETA-GALACTOSIDE-BINDING LECTIN (Gallus gallus) |
PF00337(Gal-bind_lectin) | 8 | HIS A 45ASN A 47ARG A 49HIS A 53ASN A 62TRP A 69GLU A 72ARG A 74 | None | 0.77A | 6b94A-3duiA:24.3 | 6b94A-3duiA:68.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i8t | GALECTIN-4 (Mus musculus) |
PF00337(Gal-bind_lectin) | 6 | HIS A 75ASN A 77ARG A 79ASN A 89TRP A 96GLU A 99 | LBT A 165 (-4.0A)GOL A 167 ( 3.2A)LBT A 165 (-2.6A)LBT A 165 (-3.8A)LBT A 165 ( 3.6A)LBT A 165 (-3.0A) | 0.39A | 6b94A-3i8tA:19.4 | 6b94A-3i8tA:24.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3m2m | GALECTIN-1 (Rattusnorvegicus) |
PF00337(Gal-bind_lectin) | 8 | HIS A 44ASN A 46ARG A 48HIS A 52ASN A 61TRP A 68GLU A 71ARG A 73 | LAT A 999 (-3.7A)LAT A 999 (-4.1A)LAT A 999 (-3.1A)LAT A 999 (-3.9A)LAT A 999 (-3.7A)LAT A 999 (-3.7A)LAT A 999 (-3.0A)LAT A 999 ( 4.7A) | 0.33A | 6b94A-3m2mA:26.7 | 6b94A-3m2mA:92.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nv3 | GALECTIN 9 SHORTISOFORM VARIANT (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 235ASN A 237ARG A 239ASN A 248TRP A 255GLU A 258ARG A 260 | GAL A 501 (-3.9A)GAL A 501 (-3.8A)NAG A 502 ( 2.7A)GAL A 501 (-3.8A)GAL A 501 (-3.6A)NAG A 502 ( 2.7A)NAG A 502 (-4.0A) | 0.41A | 6b94A-3nv3A:19.4 | 6b94A-3nv3A:23.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ojb | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 5 | HIS A 53ASN A 55ASN A 66TRP A 73ARG A 78 | None | 0.48A | 6b94A-3ojbA:19.7 | 6b94A-3ojbA:36.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rxy | NIF3 PROTEIN (Sphaerobacterthermophilus) |
no annotation | 4 | HIS A 88ARG A 141GLU A 87ARG A 80 | None | 0.98A | 6b94A-3rxyA:undetectable | 6b94A-3rxyA:15.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s47 | MANDELATERACEMASE/MUCONATELACTONIZING PROTEIN (Clostridiumbeijerinckii) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 4 | ASN A 322HIS A 282GLU A 336ARG A 280 | NoneNoneNone MG A 402 (-4.7A) | 1.11A | 6b94A-3s47A:undetectable | 6b94A-3s47A:14.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3saj | GLUTAMATE RECEPTOR 1 (Rattusnorvegicus) |
PF01094(ANF_receptor) | 4 | HIS A 209ASN A 231HIS A 355GLU A 352 | NAG A 700 (-4.2A)NAG A 700 (-1.9A)NoneNone | 1.15A | 6b94A-3sajA:undetectable | 6b94A-3sajA:12.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t6c | PUTATIVE MAND FAMILYDEHYDRATASE (Pantoeaananatis) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 4 | ASN A 338HIS A 298GLU A 352ARG A 296 | NoneNoneGCO A 601 (-2.8A)GCO A 601 (-4.1A) | 1.14A | 6b94A-3t6cA:undetectable | 6b94A-3t6cA:11.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tc9 | HYPOTHETICALHYDROLASE (Bacteroidesthetaiotaomicron) |
PF01833(TIG) | 4 | ARG A 386ASN A 426GLU A 446ARG A 445 | NoneNonePO4 A 481 ( 4.5A)PO4 A 481 (-4.1A) | 1.12A | 6b94A-3tc9A:undetectable | 6b94A-3tc9A:11.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ty1 | HYPOTHETICAL ALDOSE1-EPIMERASE (Klebsiellapneumoniae) |
PF14486(DUF4432) | 4 | HIS A 229ASN A 129TRP A 101GLU A 130 | SO4 A 513 (-3.9A)NoneNoneNone | 1.12A | 6b94A-3ty1A:undetectable | 6b94A-3ty1A:12.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vkg | DYNEIN HEAVY CHAIN,CYTOPLASMIC (Dictyosteliumdiscoideum) |
PF03028(Dynein_heavy)PF07728(AAA_5)PF08393(DHC_N2)PF12774(AAA_6)PF12775(AAA_7)PF12777(MT)PF12780(AAA_8)PF12781(AAA_9) | 4 | ASN A2547ARG A2543HIS A2661GLU A2550 | None | 1.11A | 6b94A-3vkgA:undetectable | 6b94A-3vkgA:2.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3vv1 | PROTEIN LEC-6 (Caenorhabditiselegans) |
PF00337(Gal-bind_lectin) | 7 | HIS A 60ASN A 62ARG A 64ASN A 73TRP A 80GLU A 83ARG A 85 | GAL A 201 (-3.8A)GAL A 201 (-3.9A)FUC A 202 (-2.7A)GAL A 201 (-3.8A)GAL A 201 ( 3.8A)FUC A 202 (-2.7A)FUC A 202 ( 4.1A) | 0.49A | 6b94A-3vv1A:18.2 | 6b94A-3vv1A:31.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) |
PF00337(Gal-bind_lectin) | 6 | HIS A 62ARG A 66ASN A 75TRP A 83GLU A 86ARG A 88 | LAT A 201 (-3.9A)LAT A 201 (-3.0A)LAT A 201 (-4.1A)LAT A 201 (-3.8A)LAT A 201 (-2.8A)LAT A 201 (-4.4A) | 0.55A | 6b94A-3wg1A:14.7 | 6b94A-3wg1A:20.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3wuc | GALECTIN (Xenopus laevis) |
PF00337(Gal-bind_lectin) | 4 | HIS A 47ASN A 49ARG A 32TRP A 71 | GAL A 202 ( 3.9A)GAL A 202 (-4.0A)GAL A 202 (-2.8A)GAL A 202 ( 3.7A) | 1.13A | 6b94A-3wucA:23.9 | 6b94A-3wucA:42.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3wuc | GALECTIN (Xenopus laevis) |
PF00337(Gal-bind_lectin) | 6 | HIS A 47ASN A 49ARG A 51ASN A 64TRP A 71GLU A 74 | GAL A 202 ( 3.9A)GAL A 202 (-4.0A)GLC A 201 (-2.7A)GAL A 202 (-3.9A)GAL A 202 ( 3.7A)GLC A 201 (-2.8A) | 0.35A | 6b94A-3wucA:23.9 | 6b94A-3wucA:42.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3wud | GALECTIN (Xenopus laevis) |
PF00337(Gal-bind_lectin) | 8 | HIS A 45ASN A 47ARG A 49HIS A 52ASN A 62TRP A 69GLU A 72ARG A 74 | GAL A 202 (-3.8A)GAL A 202 (-4.0A)GLC A 201 (-2.7A)SO4 A 203 (-3.9A)GAL A 202 (-3.9A)GAL A 202 (-3.9A)GLC A 201 (-2.7A)GLC A 201 (-4.0A) | 1.00A | 6b94A-3wudA:25.3 | 6b94A-3wudA:60.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wv6 | GALECTIN-9 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 4 | HIS A 61ASN A 63ARG A 44TRP A 82 | GAL A 402 (-3.9A)GAL A 402 (-3.9A)GAL A 402 ( 4.9A)GAL A 402 (-3.7A) | 1.04A | 6b94A-3wv6A:19.4 | 6b94A-3wv6A:12.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wv6 | GALECTIN-9 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 61ASN A 63ARG A 65ASN A 75TRP A 82GLU A 85ARG A 87 | GAL A 402 (-3.9A)GAL A 402 (-3.9A)BGC A 403 (-2.7A)GAL A 402 (-4.0A)GAL A 402 (-3.7A)BGC A 403 (-2.9A)BGC A 403 (-4.1A) | 0.38A | 6b94A-3wv6A:19.4 | 6b94A-3wv6A:12.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wv6 | GALECTIN-9 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 235ASN A 237ARG A 239ASN A 248TRP A 255GLU A 258ARG A 260 | GAL A 404 (-4.0A)GAL A 404 (-4.1A)GLC A 405 (-2.7A)GAL A 404 (-3.7A)GAL A 404 ( 3.7A)GLC A 405 ( 2.8A)GLC A 405 (-4.3A) | 0.54A | 6b94A-3wv6A:19.4 | 6b94A-3wv6A:12.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3zxe | GALECTIN-7 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 6 | HIS A 49ASN A 51ARG A 53ASN A 62TRP A 69GLU A 72 | PGZ A 1 (-3.9A)PGZ A 1 (-3.8A)PGZ A 1 (-3.6A)PGZ A 1 (-3.8A)PGZ A 1 (-4.0A)PGZ A 1 (-3.5A) | 0.25A | 6b94A-3zxeA:20.2 | 6b94A-3zxeA:38.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3zxe | GALECTIN-7 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 6 | HIS A 49ASN A 51ARG A 53TRP A 69GLU A 72ARG A 74 | PGZ A 1 (-3.9A)PGZ A 1 (-3.8A)PGZ A 1 (-3.6A)PGZ A 1 (-4.0A)PGZ A 1 (-3.5A)None | 0.62A | 6b94A-3zxeA:20.2 | 6b94A-3zxeA:38.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4agv | GALECTIN (Cinachyrella) |
PF00337(Gal-bind_lectin) | 5 | ARG A 47ASN A 60TRP A 68GLU A 71ARG A 73 | None | 0.60A | 6b94A-4agvA:16.9 | 6b94A-4agvA:23.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bmb | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 6 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | LAT A1155 (-3.9A)LAT A1155 (-3.9A)LAT A1155 (-2.7A)LAT A1155 (-3.9A)LAT A1155 (-3.6A)LAT A1155 (-3.0A) | 0.42A | 6b94A-4bmbA:18.9 | 6b94A-4bmbA:29.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fqz | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 5 | HIS A 65ASN A 67ARG A 45ASN A 79TRP A 86 | GAL A 401 (-4.0A)GAL A 401 (-4.2A)GAL A 401 (-2.8A)GAL A 401 (-3.8A)GAL A 401 (-3.5A) | 1.27A | 6b94A-4fqzA:18.2 | 6b94A-4fqzA:16.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fqz | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 6 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | GAL A 401 (-4.0A)GAL A 401 (-4.2A)BGC A 402 ( 2.5A)GAL A 401 (-3.8A)GAL A 401 (-3.5A)BGC A 402 ( 3.3A) | 0.46A | 6b94A-4fqzA:18.2 | 6b94A-4fqzA:16.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fqz | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 229ASN A 231ARG A 233ASN A 242TRP A 249GLU A 252ARG A 254 | None | 0.39A | 6b94A-4fqzA:18.2 | 6b94A-4fqzA:16.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gf8 | PEPTIDE ABCTRANSPORTER,PERIPLASMICPEPTIDE-BINDINGPROTEIN (Vibrio cholerae) |
PF00496(SBP_bac_5) | 4 | ASN A 46ASN A 41GLU A 517ARG A 508 | None | 1.12A | 6b94A-4gf8A:undetectable | 6b94A-4gf8A:9.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gqb | PROTEIN ARGININEN-METHYLTRANSFERASE5 (Homo sapiens) |
PF05185(PRMT5)PF17285(PRMT5_TIM)PF17286(PRMT5_C) | 4 | HIS A 549ARG A 193HIS A 190GLU A 224 | None | 1.06A | 6b94A-4gqbA:undetectable | 6b94A-4gqbA:7.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hl0 | GALECTIN (Toxascarisleonina) |
PF00337(Gal-bind_lectin) | 4 | HIS A 57ASN A 70TRP A 77GLU A 80 | None | 0.39A | 6b94A-4hl0A:20.5 | 6b94A-4hl0A:18.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hl0 | GALECTIN (Toxascarisleonina) |
PF00337(Gal-bind_lectin) | 4 | HIS A 57TRP A 77GLU A 80ARG A 82 | None | 0.83A | 6b94A-4hl0A:20.5 | 6b94A-4hl0A:18.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hl0 | GALECTIN (Toxascarisleonina) |
PF00337(Gal-bind_lectin) | 6 | HIS A 192ASN A 194ARG A 196ASN A 205TRP A 212GLU A 215 | None | 0.35A | 6b94A-4hl0A:20.5 | 6b94A-4hl0A:18.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hnl | MANDELATERACEMASE/MUCONATELACTONIZING ENZYME (Enterococcusgallinarum) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 4 | ASN A 320HIS A 280GLU A 334ARG A 278 | None | 1.17A | 6b94A-4hnlA:undetectable | 6b94A-4hnlA:10.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ihc | MANDELATERACEMASE/MUCONATELACTONIZING PROTEIN (Dickeyaparadisiaca) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 4 | ASN A 338HIS A 298GLU A 352ARG A 296 | NoneNoneFMT A 503 (-3.2A)FMT A 503 (-4.1A) | 1.15A | 6b94A-4ihcA:undetectable | 6b94A-4ihcA:11.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4il1 | CALMODULIN,CALCINEURIN SUBUNITB TYPE 1,SERINE/THREONINE-PROTEIN PHOSPHATASE 2BCATALYTIC SUBUNITALPHA ISOFORM (Rattusnorvegicus) |
PF00149(Metallophos)PF13499(EF-hand_7) | 4 | HIS A 532ASN A 483HIS A 425GLU A 485 | None | 1.16A | 6b94A-4il1A:undetectable | 6b94A-4il1A:7.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jo0 | CMLA (Streptomycesvenezuelae) |
PF12706(Lactamase_B_2) | 4 | ASN A 462ASN A 406GLU A 468ARG A 467 | None | 0.94A | 6b94A-4jo0A:undetectable | 6b94A-4jo0A:9.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mte | ZINC UPTAKEREGULATION PROTEIN (Escherichiacoli) |
PF01475(FUR) | 4 | HIS A 134HIS A 96ASN A 135GLU A 118 | None ZN A 202 (-3.2A)NoneNone | 1.08A | 6b94A-4mteA:undetectable | 6b94A-4mteA:22.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homo sapiens) |
PF00644(PARP)PF02877(PARP_reg)PF05406(WGR) | 4 | ASN C 767ARG C 865HIS C 909GLU C 688 | None | 0.85A | 6b94A-4oqaC:undetectable | 6b94A-4oqaC:10.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wvw | GALECTIN (Gallus gallus) |
PF00337(Gal-bind_lectin) | 6 | HIS A 64ASN A 66ARG A 68ASN A 78TRP A 85GLU A 88 | SLT A 201 (-3.9A)SLT A 201 (-3.8A)SLT A 201 (-2.7A)SLT A 201 (-3.9A)SLT A 201 (-3.6A)SLT A 201 (-2.8A) | 0.38A | 6b94A-4wvwA:19.3 | 6b94A-4wvwA:32.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xzp | GALECTIN-4 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 6 | HIS A 63ASN A 65ARG A 67ASN A 77TRP A 84GLU A 87 | None | 0.53A | 6b94A-4xzpA:17.5 | 6b94A-4xzpA:24.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4y1y | GALECTIN-1 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 8 | HIS A 44ASN A 46ARG A 48HIS A 52ASN A 61TRP A 68GLU A 71ARG A 73 | GAL A 201 (-3.9A)GAL A 201 (-4.4A)6S2 A 202 (-2.8A)GAL A 201 (-4.2A)GAL A 201 (-3.8A)GAL A 201 ( 4.1A)6S2 A 202 (-2.6A)6S2 A 202 (-3.8A) | 0.36A | 6b94A-4y1yA:28.7 | 6b94A-4y1yA:78.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4y26 | GALECTIN-7 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 49ASN A 51ARG A 53ASN A 62TRP A 69GLU A 72ARG A 74 | GAL A 201 (-3.9A)GAL A 201 (-4.1A)6S2 A 202 (-2.9A)GAL A 201 (-3.7A)GAL A 201 (-3.5A)6S2 A 202 (-2.8A)6S2 A 202 (-3.5A) | 0.68A | 6b94A-4y26A:20.0 | 6b94A-4y26A:35.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ym3 | GALECTIN-4 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 6 | HIS A 236ASN A 238ARG A 240ASN A 249TRP A 256GLU A 259 | LAT A 401 (-3.9A)LAT A 401 (-4.0A)LAT A 401 (-2.6A)LAT A 401 (-3.7A)LAT A 401 ( 3.8A)LAT A 401 (-3.1A) | 0.33A | 6b94A-4ym3A:18.7 | 6b94A-4ym3A:24.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zwe | DEOXYNUCLEOSIDETRIPHOSPHATETRIPHOSPHOHYDROLASESAMHD1 (Homo sapiens) |
PF01966(HD) | 4 | HIS A 210ASN A 207ARG A 206GLU A 234 | DGT A 701 (-4.5A)DGT A 701 (-3.6A)DGT A 701 ( 4.2A)None | 1.13A | 6b94A-4zweA:undetectable | 6b94A-4zweA:8.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5a31 | ANAPHASE-PROMOTINGCOMPLEX SUBUNIT 1ANAPHASE-PROMOTINGCOMPLEX SUBUNIT 5 (Homo sapiens;Homo sapiens) |
PF12859(ANAPC1)PF12862(ANAPC5) | 4 | HIS A 645ARG A 15HIS O 526GLU A 611 | None | 1.14A | 6b94A-5a31A:undetectable | 6b94A-5a31A:4.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dux | GALECTIN-4 (Homo sapiens) |
no annotation | 6 | HIS B 63ASN B 65ARG B 67ASN B 77TRP B 84GLU B 87 | LAT B 201 (-3.9A)LAT B 201 (-3.8A)LAT B 201 (-2.6A)LAT B 201 (-3.9A)LAT B 201 ( 3.8A)LAT B 201 (-2.4A) | 0.31A | 6b94A-5duxB:19.5 | 6b94A-5duxB:27.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dux | GALECTIN-4 (Homo sapiens) |
no annotation | 5 | HIS B 63ASN B 77TRP B 84GLU B 87ARG B 89 | LAT B 201 (-3.9A)LAT B 201 (-3.9A)LAT B 201 ( 3.8A)LAT B 201 (-2.4A)LAT B 201 ( 3.7A) | 1.11A | 6b94A-5duxB:19.5 | 6b94A-5duxB:27.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gzg | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 6 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | LAT A 201 (-3.9A)LAT A 201 (-4.2A)LAT A 201 (-2.3A)LAT A 201 (-3.6A)LAT A 201 (-3.7A)LAT A 201 (-3.0A) | 0.41A | 6b94A-5gzgA:18.7 | 6b94A-5gzgA:23.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5h9p | GALECTIN-3 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 158ASN A 160ARG A 162ASN A 174TRP A 181GLU A 184ARG A 186 | TD2 A 301 (-3.8A)TD2 A 301 (-4.0A)TD2 A 301 (-2.8A)TD2 A 301 (-3.8A)TD2 A 301 ( 3.7A)TD2 A 301 (-2.9A)TD2 A 301 (-3.9A) | 0.45A | 6b94A-5h9pA:19.8 | 6b94A-5h9pA:32.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jp5 | GALECTIN-5 (Rattusnorvegicus) |
PF00337(Gal-bind_lectin) | 7 | HIS A 57ASN A 59ARG A 61ASN A 70TRP A 77GLU A 80ARG A 82 | PEG A 201 (-3.7A)PEG A 201 ( 4.8A)PEG A 201 (-3.0A)PEG A 201 (-3.6A)PEG A 201 (-2.8A)PEG A 201 (-3.3A)None | 0.52A | 6b94A-5jp5A:19.3 | 6b94A-5jp5A:25.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kbp | GLYCOSYL HYDROLASE,FAMILY 38 (Enterococcusfaecalis) |
PF01074(Glyco_hydro_38)PF07748(Glyco_hydro_38C)PF09261(Alpha-mann_mid) | 4 | ASN A 347ARG A 368GLU A 17ARG A 16 | None | 0.75A | 6b94A-5kbpA:undetectable | 6b94A-5kbpA:7.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5nfb | GALECTIN-3 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 158ASN A 160ARG A 162ASN A 174TRP A 181GLU A 184ARG A 186 | 8VT A 301 (-3.9A)8VT A 301 (-4.0A)8VT A 301 (-2.7A)8VT A 301 (-3.8A)8VT A 301 ( 3.7A)8VT A 301 (-2.7A)8VT A 301 (-3.4A) | 0.48A | 6b94A-5nfbA:19.8 | 6b94A-5nfbA:37.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5nlh | GALECTIN (Gallus gallus) |
no annotation | 6 | HIS A 48ASN A 50ARG A 52ASN A 61TRP A 68GLU A 71 | LBT A 201 (-3.5A)LBT A 201 (-3.7A)LBT A 201 (-2.6A)LBT A 201 (-3.9A)LBT A 201 (-3.0A)LBT A 201 (-2.1A) | 0.31A | 6b94A-5nlhA:19.3 | 6b94A-5nlhA:32.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5td6 | FOG-3 PROTEIN (Caenorhabditiselegans) |
PF07742(BTG) | 4 | HIS A 96ARG A 100ASN A 93GLU A 53 | None | 1.11A | 6b94A-5td6A:undetectable | 6b94A-5td6A:17.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vyl | INNER TEGUMENTPROTEIN (Humanalphaherpesvirus1) |
PF03970(Herpes_UL37_1) | 4 | HIS A 95ARG A 543GLU A 108ARG A 158 | None | 1.05A | 6b94A-5vylA:undetectable | 6b94A-5vylA:10.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xg8 | GALACTOSIDE-BINDINGSOLUBLE LECTIN 13 (Homo sapiens) |
no annotation | 4 | HIS A 53HIS A 57ASN A 65GLU A 75 | GOL A 201 (-3.5A)NoneGOL A 201 (-3.7A)GOL A 201 (-2.8A) | 1.07A | 6b94A-5xg8A:17.9 | 6b94A-5xg8A:23.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fof | GALECTIN-3,GALECTIN-3 (Homo sapiens) |
no annotation | 4 | ARG C 186ASN C 166GLU C 165ARG C 162 | LAT C 301 (-4.0A)NoneLAT C 301 ( 4.7A)LAT C 301 (-2.7A) | 1.16A | 6b94A-6fofC:19.2 | 6b94A-6fofC:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fof | GALECTIN-3,GALECTIN-3 (Homo sapiens) |
no annotation | 7 | HIS C 158ASN C 160ARG C 162ASN C 174TRP C 181GLU C 184ARG C 186 | LAT C 301 (-3.8A)LAT C 301 (-4.1A)LAT C 301 (-2.7A)LAT C 301 (-3.8A)LAT C 301 (-3.8A)LAT C 301 ( 2.8A)LAT C 301 (-4.0A) | 0.59A | 6b94A-6fofC:19.2 | 6b94A-6fofC:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 7mdh | PROTEIN (MALATEDEHYDROGENASE) (Sorghum bicolor) |
PF00056(Ldh_1_N)PF02866(Ldh_1_C) | 4 | ASN A 176HIS A 229ASN A 178ARG A 140 | None ZN A 501 (-2.9A)NoneNone | 1.16A | 6b94A-7mdhA:undetectable | 6b94A-7mdhA:13.64 |